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Graphical abstract 
 
Synopsis. CopA is a Cu(I)-exporting transmembrane P1B-type ATPase from Bacillus subtilis. 
Electrospray ionization mass spectrometric analysis of Cu(I)-binding to the N-terminal domains of 
CopA (CopAab) reveals formation of a dimeric form, Cu6(CopAab)2, at > 1 Cu(I)/protein.  Dimeric 
forms persist in the presence of bacillithiol. 
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Highlights 
 CopA is a Cu(I)-exporting transmembrane P1B-type ATPase from Bacillus subtilis 
 ESI-MS studies of the N-terminal domains of CopA (CopAab) reveals copper-bound forms 
 At low copper (up to 1 per protein), singly and doubly Cu(I)-bound forms predominate 
 At higher copper (> 1 per protein), dimeric CopAab containing six Cu(I) predominate 
 Dimeric CopAab persists in the presence of bacillithiol at physiological ratios 
 
 
 
Keywords: Copper trafficking, electrospray ionisation mass spectrometry, Bacillus subtilis, copper-
mediated association, bacillithiol 
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ABSTRACT 
CopA is a Cu(I)-exporting transmembrane P1B-type ATPase from Bacillus subtilis. It contains two N-
terminal cytoplasmic domains, CopAab, which bind Cu(I) with high affinity and to form higher-order 
complexes with multiple Cu(I) ions. To determine the precise nature of these species, electrospray 
ionization mass spectrometry (ESI-MS) under non-denaturing conditions was employed.  Up to 1 Cu 
per CopAab resulted in Cu coordination to one or both CopAab domains. At > 1 Cu/CopAab, two 
distinct dimeric charge state envelopes were observed, corresponding to distinct conformations, 
each with Cu6(CopAab)2 as its major form. The influence of the physiologically relevant low 
molecular weight thiol bacillithiol (BSH) on Cu(I)-binding to CopAab was assessed. Dimeric CopAab 
persisted in the presence of BSH, with previously undetected Cu7(CopAab)2 and Cu6(CopAab)2(BSH) 
forms apparent. 
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Introduction 
Copper is an essential metal transported by dedicated copper chaperone proteins that deliver it to 
copper-requiring enzymes and detoxify it when in excess [1]. The latter process, which involves 
copper export across the cytoplasmic membrane, is essential to cell survival due to the potentially 
toxic nature of elevated cellular copper levels. Translocation of Cu(I) across the Bacillus subtilis cell 
membrane takes place via the integral membrane P-type ATPase, CopA [2, 3]. 
P-type ATPase protein family members typically contain a central core of transmembrane 
helices, an actuator domain (A-domain) and an ATP-binding domain (ATP-BD), comprising two 
distinct sub-domains involved in nucleotide-binding (N) and phosphorylation (P) [4]. The P-type 
ATPases are further divided into subclasses based upon several structural features [5]. The P1B-type 
ATPases contain an additional two helices in the transmembrane core, and are also distinguished by 
possession of a Cys-Pro-Cys (CPC) transmembrane metal-binding motif located in helix 4, and one or 
more soluble cytoplasmic domains (MBDs) at the N- and, sometimes, C-termini. The two N-terminal 
cytoplasmic MBDs in B. sutbilis CopA, CopAab, possess the same βαββαβ fold as that of the B. 
subtilis Atx1 (antioxidant protein 1, a eukaryotic copper chaperone)-like metallochaperone CopZ. 
Each individual domain, CopAa and CopAb, contains a conserved MXCXXC copper-binding motif with 
two solvent-exposed cysteines located between the end of the first loop and the beginning of the 
first α-helix [6]. 
The exact role of MBDs in ATPase function is unclear. It has been proposed that, in some 
cases, they are required for copper transfer activity [7, 8], but in others it has been shown that they 
are not [9], and available structural data indicate that they are too remote from the transmembrane 
transport site to be directly involved. However, protein-protein interaction and protein 
phosphorylation studies, together with their proximity to the actuator and nucleotide-binding 
domains, have led to a model in which the MBDs perform a regulatory role through interactions with 
these domains that modulates not only Cu(I) transport activity but (in eukaryotes) also trafficking 
between sub-cellular locations [10-13]. 
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Cu(I) binding to the MBDs of CopA, both as isolated domains (CopAa and CopAb) [14, 15] 
and as a two domain protein, CopAab [16], has been characterised previously using spectroscopic 
and bioanalytical techniques. Initial binding of Cu(I) to CopAab occurs with high affinity (K ≈ 4 × 1017 
M-1) [17], and CopAab was shown to undergo Cu(I)-mediated dimerization above 1 Cu/protein. Data 
from AUC and SEC suggested that a small portion of dimer (≈ 5%) was present at 1 Cu/protein and by 
2 Cu/protein the association state was fully dimeric [16]. Dimeric CopAab was also shown to be 
capable of accommodating multiple Cu(I) ions. Copper binding by CopAab at a ratio of 2 Cu/protein 
resulted in a highly luminescent species, predicted to be due to a Cu4(CopAab)2 form [17]. However, 
luminescence quenching beyond a ratio of 2:1 suggested that dimeric CopAab may be able to bind 
additional Cu(I) ions [17]. Recent studies of a 1:1 mixture of separate CopAa and CopAb showed that 
the domains do not form a stable complex in the absence of a covalent linker, though there was 
evidence of a weak interaction between them [18]. 
The regulation of cellular Cu(I) levels could be influenced by cytoplasmic low molecular 
weight thiol-containing species. For example, glutathione may serve as a copper-binding 
intermediate between the eukaryotic importer Ctr1 (high affinity copper transporter 1) and 
cytoplasmic chaperones [19]. A role in metal trafficking has also been suggested for bacillithiol (BSH), 
the cytoplasmic low molecular weight thiol of B. subtilis, and related species [20-22]. BSH has been 
shown to detoxify xenobiotic compounds and antibiotics and serve a protective effect against 
cysteine oxidation through protein S-bacillithiolation [20, 21]. Cu(I)-induced copZA induction was 
elevated in BSH-null mutants of B. subtilis, suggesting the absence of BSH led to elevated labile Cu(I) 
levels and the presence of BSH plays a role in Cu(I) buffering. Recent studies of Cu(I)-binding to B. 
subtilis CopZ using electrospray ionisation mass spectrometry (ESI-MS) under non-denaturing 
conditions, in the absence and presence of BSH, revealed bacillithiolation and a range of BSH 
adducts of CopZ in which the thiol most likely serves as an exogenous Cu(I) ligand [22]. Low 
molecular weight thiols have previously been shown to influence CopAab association state 
behaviour [17], but the effects of BSH have not been investigated. 
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Despite the previous characterisation of complex Cu(I) binding to CopAab, the precise nature 
of species and mixtures of species which form as Cu(I) levels vary is unknown. The recent 
investigation of Cu(I)-binding to CopZ using ESI-MS revealed precise information about the nature of 
Cu(I)-CopZ species, suggesting that similar high resolution information about CopAab could be 
available. Thus, non-denaturing ESI-MS studies of Cu(I)-binding to CopAab, in the absence and 
presence of BSH, were carried out. The data are consistent with solution spectroscopic and 
bioanalytical studies, demonstrating Cu(I)-mediated dimerization of CopAab, and the formation of a 
Cu6(CopAab)2 form at high copper loadings. While the non-physiological thiol dithiothreitol (DTT) 
severely inhibited dimerization of CopAab, BSH, at ratios to CopAab of 1-10, was found to promote 
dimerization and to influence the distribution of Cu(I)-bound species. In contrast to CopZ [22], 
bacillithiolation and BSH-adduct formation were not readily detected. 
 
Materials and methods 
Purification of CopAab. Overexpression and purification of CopAab was carried out as previously 
described [16], except for the inclusion of an additional step to remove contaminating nucleic acids 
following ion exchange chromatography. (NH4)2SO4 was added to fractions containing CopAab 
(determined by SDS-PAGE analysis), to a final concentration of 3 M. The protein solution was then 
loaded onto a 15 mL phenyl-sepharose hydrophobic interaction chromatography (HIC) column (GE 
Healthcare), previously equilibrated with 5 CV 100 mM HEPES, 100 mM NaCl, 3 M (NH4)2SO4, 15 mM 
DTT, pH 7.0. The column was washed with 20 CV binding buffer before applying a 100 mL gradient of 
3 – 0 M (NH4)2SO4. Fractions containing CopAab (as determined by SDS-PAGE analysis) were buffer 
exchanged into 100 mM HEPES, 100 mM NaCl, pH 7.0 and concentrated to < 2.5 mL, using a 
centrifugal ultrafiltration unit (Vivaspin; Millipore) at 8000  g and 4 °C. The protein solution was 
passed through a 0.45 μm filter (Sartorius) and DTT added to a final concentration of 15 mM before 
applying to the Sephacryl S-100 gel filtration column. Subsequent purification steps were carried out 
as previously described [16].  
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Mass spectrometry. ESI-MS samples of CopAab were prepared by first adding 15 mM DTT 
(Formedium) and removing excess reductant by passage down a G25 Sephadex column (PD10, GE 
Healthcare) in an anaerobic glovebox (Faircrest Engineering, O2 concentration < 2 ppm) using 20 mM 
ammonium acetate (Sigma), pH 7.4, as the elution buffer. Protein concentrations were calculated 
using an extinction coefficient, ε276 nm, of 5800 M
-1 cm-1 [17], before anaerobic addition of Cu(I) using 
a microsyringe (Hamilton). UV-visible absorbance spectra were recorded on a Jasco V-550 
spectrophotometer. To prepare Cu(I)-bound CopAab samples, a deoxygenated solution of Cu(I)Cl 
prepared in 100 mM HCl (Sigma), 1 M NaCl was added to anaerobic, reduced CopAab using a 
microsyringe (Hamilton) in an anaerobic glovebox. Unbound Cu(I) was removed by passage of the 
sample down a G25 Sephadex column (PD10, GE Healthcare) equilibrated with 20 mM ammonium 
acetate, pH 7.4. The protein sample was diluted with 20 mM ammonium acetate to a working 
sample concentration of 5 µM. Thiol experiments were carried out using dithiothreitol (DTT) 
(Formedium) or BSH (synthesised as described previously [23]) and prepared anaerobically using 
deoxygenated LC-MS grade water (HiPerSolv, VWR). Solutions of CopAab were prepared at 4.0 
Cu(I)/protein (as described above), where thiol solution was added to yield ratios of 1, 5, 10, or 25 
thiol per protein. Mass spectra were acquired using a Bruker micrOTOF-QIII electrospray ionisation 
(ESI) time-of-flight (TOF) mass spectrometer (Bruker Daltonics, Coventry, UK), in positive ion mode. 
The ESI-TOF was calibrated using ESI-L Low Concentration Tuning Mix (Agilent Technologies, San 
Diego, CA). Native protein samples were introduced to the ESI source at 4 °C via a syringe pump 
(Cole-Parmer) at 5 mL/min, and data acquired for 2 min, with ions scanned between 500 – 3000 m/z. 
MS acquisition was controlled using Bruker oTOF Control software, with parameters as follows: dry 
gas flow 5 L/min, nebuliser gas pressure 0.8 Bar, dry gas 180 °C, capillary voltage 4500 V, offset 500 
V, isCID (in-source collision induced dissociation) energy 0 eV, quadrupole radio frequency (RF) 
stepping set at 2000 Vpp (peak to peak volts; 25%) and 3200 Vpp (75%). Processing and analysis of 
MS experimental data were carried out using Compass DataAnalysis version 4.1 (Bruker Daltonik, 
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Bremen, Germany). The spectra were deconvoluted using the ESI Compass version 1.3 Maximum 
Entropy deconvolution algorithm over a mass range of 15000 – 35000 Da. Exact masses were 
determined from peak centroids, with 3-point Gaussian smoothing applied only to spectra acquired 
in the presence of BSH. Predicted masses are given as the isotope average of the neutral protein or 
protein complex, in which Cu(I)-binding is expected to be charge compensated For ions due to 
CopAab-Cu species, m/z values corresponded to [M + x(Cu) + (n-x)H]n+/n, where M is the molecular 
mass of the protein and x the number of coordinated Cu+ ions, which offsets the number of protons 
required to achieve the observed charge state (n+) [22, 24]. 
 
Results and Discussion 
ESI-MS studies reveal Cu(I)-mediated dimerization of CopAab and formation of Cu6(CopAab)2 
ESI-MS under non-denaturing conditions preserves protein structure and non-covalent protein-
metal and protein-protein interactions, and can provide high resolution information about the 
species present in complex mixtures [24, 25]. The m/z mass spectra for CopAab containing 0.5, 1.0, 
2.0 and 4.0 Cu/protein are presented in Fig. 1. Three charge state envelopes were observed, 
corresponding to monomeric (+8, +9) and dimeric (+11 – +14; and +16 – +18) forms of CopAab. At 
0.5 and 1.0 Cu/CopAab (Fig. 1A and B, respectively), the monomer charge envelope (8+, 9+) was 
predominant, with no significant intensity due to dimeric charge states. The dimer charge states 
increased in intensity at higher levels of copper, such that they matched or exceeded the monomeric 
charge state envelope in intensity at a level of 4.0 Cu/CopAab (Fig. 1C and D). 
Deconvoluted mass spectra in the monomer and dimer regions are shown on the right of 
Fig. 1. These illustrate that CuCopAab and Cu2CopAab (see Table 1 for observed and predicted 
masses) were the most abundant species at 0.5 and 1.0 Cu/CopAab (Fig. 1A and B); here copper is 
bound at one or both of the copper-binding domains (CopAa and/or CopAb). The relative intensity of 
Cu2CopAab increased to become the dominant copper-bound peak at 2.0 Cu/protein.  The structure 
of B. subtilis CopAab revealed that the two copper-binding motifs are remote from one another and 
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cannot participate in binding the same Cu(I) ion [16]. NMR data also established that CopZ interacts 
with, and can deliver Cu(I) to, both CopAab domains with no observable preference [16, 26]. 
Although the ESI-MS data cannot determine which domain is bound to Cu(I), the data are consistent 
with binding occurring to both domains without preference, such that a mixture of apo, singly and 
doubly Cu(I)-bound CopAab species was observed at lower copper levels. 
At 2 Cu/CopAab, peaks were also observed in the dimer region, with the major peak 
corresponding to Cu6(CopAab)2, with much smaller peaks due to Cu5(CopAab)2 and Cu4(CopAab)2 
(Fig. 1C). A very similar pattern but with greater relative abundance in the dimer region (such that it 
was greater than that of the monomer region) was observed at 4 Cu/CopAab (Fig. 1D). The 
consistently low intensity of Cu4(CopAab)2 and Cu5(CopAab)2 peaks and the lack of other higher 
order Cu(I)-bound forms suggest that Cu6(CopAab)2 represents a particularly stable form of dimeric 
CopAab. Relative abundances of species (mean values over n = 3) are shown in Fig. S1. 
The ESI-MS data are consistent with previous solution spectroscopic studies demonstrating 
complex copper-binding behaviour of CopAab, with Cu(I)-mediated dimerisation occurring above a 
level of 1 Cu/protein. We might have expected the protein to be fully dimeric at 2 Cu/CopAab. In 
reality, some monomeric species remained, even at the highest level of copper. However, the 
observation of monomer forms of dimeric species is a common observation by ESI-MS, where the 
monomer-monomer interactions do not quantitatively survive the ionisation process [24, 27]. 
Previous spectroscopic studies demonstrated the formation of a luminescent species that is 
characteristic of a solvent excluded multi-nuclear Cu(I) centre [17]. This was observed to maximise at 
~2 Cu/protein before losing intensity as further copper was added [16, 17]. From this, a model was 
proposed in which a Cu4(CopAab)2 species forms initially upon CopAab dimerization, followed by 
Cu5(CopAab)2 and Cu6(CopAab)2 species as further copper is added, with Cu7(CopAab)2 and 
Cu8(CopAab)2 forms predicted to be the end point of the Cu(I) titration [17]. The ESI-MS data are 
broadly in agreement with this, with Cu4(CopAab)2, Cu5(CopAab)2 and Cu6(CopAab)2 species 
detected. It was anticipated that the Cu4(CopAab)2 form would be dominant at 2 Cu/CopAab, but 
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this was not apparent from the ESI-MS data. This could be a result of the tendency of the CopAab 
dimer to dissociate during ionisation, with loss of some Cu(I) that may be readily picked up by 
remaining dimeric CopAab species.  However, the data clearly indicate that the Cu6(CopAab)2 form is 
highly stable, and that higher order Cu(I)-bound species are not readily formed. Thus, the ESI-MS 
data provide, for the first time, evidence of the precise nature of the Cu(I)-species formed. 
The presence of two distinct dimeric species in the m/z spectra of CopAab containing 2 or 
greater Cu/CopAab (charge states 11+, 12+, 13+, 14+ and 16+, 17+, 18+, respectively; Fig. 1) 
indicated the presence of two distinct forms of dimeric CopAab (principally Cu6(CopAab)2). These 
most likely correspond to two conformations, with the species giving rise to the higher charge states 
most likely adopting a more open structure that permits a greater extent of protonation. These 
observations could be related to previous studies of CopAab by far UV-CD, which showed that higher 
copper loadings resulted in loss of CopAab secondary structure, most likely resulting from partial 
unfolding and leading to significant conformational rearrangement [16].   
The detection of CopAab as a dimer at higher Cu loading implies that the full length protein, 
CopA, could undergo dimerization in response to Cu status under some conditions. While there is no 
in vivo data for CopA that supports this possibility, we note that metal ion transporting P-type 
ATPases have been reported to dimerize (eg [28]) and, more importantly, the Wilson’s disease 
protein, ATP7B, was recently shown to form stable dimers in vitro and in cells [29]. Deletion of the 
first four (of the six) N-terminal metal-binding domains did not disrupt dimerization, indicating that 
the dimer interface is formed by the domains that are conserved amongst Cu(I)-transporting P-type 
ATPases. 
 
ESI-MS studies reveal distinct effects of DTT and BSH on association state and Cu(I)-binding 
properties of CopAab 
The cellular cytosol is abundant in low molecular weight thiols that are capable of binding Cu(I) [30] 
and can potentially impact copper trafficking [31, 32]. Previous AUC experiments conducted with 
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CopAab at elevated Cu(I) levels in the presence of 20-fold excess of DTT illustrated that this thiol 
prevented protein dimerization, with glutathione and cysteine having a less severe effect [16]. These 
studies pre-dated the discovery of bacillithiol as a major cytoplasmic thiol in B. subtilis [33]. 
Therefore the influence of DTT and BSH on the speciation of CopAab at 4 Cu(I) per protein was 
examined using ESI-MS at thiol to protein ratios of 1, 5, 10 and 25 for both DTT and BSH. The m/z 
spectra for CopAab in the presence of DTT (Fig. S2) featured fewer peaks than the equivalent thiol-
free spectrum (Fig. 1D), comprising mostly monomeric species (+8, +9) with the more compact 
dimeric copper-bound form (+12, +13) corresponding to Cu6(CopAab)2 initially present at low 
abundance, but this was lost at ratios of DTT > 1. The less compact, higher dimeric charge states 
were entirely absent throughout. 
Deconvoluted mass spectra revealed a complex picture of speciation in the presence of DTT 
(Fig. 2). At each level of DTT/protein tested, the major copper-bound species were CuCopAab and 
Cu2CopAab (see Table 2). This suggests the presence of DTT drives the protein population towards a 
monomeric form with a fairly equal propensity for one or two copper-binding sites to be occupied. 
The ability of DTT to inhibit dimerisation may be due in part to its ability to compete well for Cu(I) 
bound by dimeric forms but less so with monomeric forms of CopAab. The affinity of DTT for Cu(I) (K 
~ 1015 M, [34]) is lower than that measured of the initial binding phase of CopAab (K ~ 1017 M) [17], 
but higher than those modelled from spectroscopic data (K ~ 105 – 109) for binding of additional 
copper ions to CopAab. 
At a 1:1 ratio of DTT to protein, in addition to the apo-, Cu and Cu2CopAab forms observed in 
the absence of DTT, a Cu4CopAab form was also observed, alone and as a DTT-adduct, along with a 
Cu6CopAab(DTT)2 adduct. Interestingly, the distribution of monomeric species remained relatively 
constant as the ratio of DTT to protein increased. Relative abundances of species (mean values over 
n = 3) are shown in Fig. S3. In all cases, DTT adducts involved the CopAab monomer binding 4 – 6 
Cu(I) ions; no DTT adducts were observed for CopAab bound to 1 or 2 Cu(I). This suggests that DTT 
most likely plays an important role in directly binding Cu(I) in these complexes, effectively replacing 
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the Cys thiols that were provided by the second CopAab molecule in dimeric CopAab species, and 
enabling monomeric CopAab to bind significantly more Cu(I) than in the absence of DTT. The 
unexpected species Cu4CopAab may represent a breakdown product of the Cu4(CopAab:DTT) 
species.  Interestingly, although DTT had a similar effect on the propensity of CopZ to dimerize in the 
presence of Cu(I), DTT complexes with CopZ were not observed by ESI-MS [22]. 
In the presence of BSH (1, 5, 10, 25/protein) the m/z spectra (Fig. S4) were significantly 
noisier, most likely reflecting ion suppression due to the presence of BSH, as previously observed for 
CopZ measurements [22]. CopAab peak envelopes were still detected, up to 25 BSH/protein, but 
beyond this level interpretation of the spectra was not possible (data not shown). The m/z spectra 
clearly contained three peak envelopes, due to monomeric (+8, +9) and two dimeric (+12 – 14; and 
+16 – 18) forms, as in the thiol-free spectrum (Fig 1D). The deconvoluted spectra, Fig. 3, remarkably 
show that in the presence of 1, 5 and 10 BSH/CopAab, there was a significant increase in the dimeric 
forms of CopAab relative to monomeric forms (see Table 2 for observed and predicted masses). 
Dimeric species included Cu5(CopAab)2 and Cu6(CopAab)2, but also featured a previously 
undetected Cu7(CopAab)2 form, as well as a BSH adduct of Cu6(CopAab)2 (Cu6(CopAab)2(BSH)). At 
higher levels of BSH (25 BSH/CopAab), the relative proportion of dimeric form eventually decreased, 
but were still observed (Fig. 3D). Relative abundances of species (mean values over n = 3) are shown 
in Fig. S5. Significantly higher ratios of BSH:CopAab could not be investigated due to ion suppression 
[22]. 
The measured affinities for initial binding of Cu(I) to CopAab and BSH are similar (K ~ 1017 M) 
[16, 22], which supports the observation of monomeric species in the presence of BSH, and 
increased abundance of monomeric CopAab at higher BSH levels. Although relatively few BSH 
adducts were detected (only Cu6(CopAab)2(BSH) at 1 – 10 BSH/protein and possibly 
Cu5(CopAab)2(BSH) at 25 BSH/protein), BSH clearly has a significant effect on Cu(I)-binding, leading 
to a distinct distribution of species observed in the presence of BSH, with CopAab dimeric forms 
detected containing between 5 to 7 Cu(I) ions, rather than between 4 to 6 Cu(I) in the absence of 
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BSH. This additional Cu(I)-binding and increased abundance of CopAab dimeric peaks suggests BSH 
may increase the copper-binding capacity by acting as an additional Cu(I) ligand; however, the 
general lack of BSH adducts means that this is unclear. We note that this is in stark contrast to CopZ, 
for which multiple BSH adducts were readily detected [22]. This may point to different roles in vivo 
for BSH with respect to formation of bacillithiolated species and to participation/cooperation in 
Cu(I)-binding by CopA N-terminal copper-binding domains and the chaperone CopZ. The 
concentration of BSH varies during growth, but is generally in the millimolar range [35]. 
Concentrations of copper trafficking proteins in B. subtilis have not been determined, but under 
copper stress conditions (0.4 mM Cu in growth media), total Cu reaches millimolar levels [3]. A CopZ 
mutant was found to accumulate ~ 3-fold less total Cu, indicating that, under these conditions, a 
large proportion of Cu is associated with CopZ, suggesting that it reaches concentrations in the 
hundreds of micromolar range [3]. Given that copZ and copA are co-expressed under the control of 
the CsoR regulator, and are significantly upregulated under copper stress conditions [36], the ratios 
of thiol to protein employed here are likely to be in the physiological range, at least under copper 
stress conditions.  Thus, data reported here and those from the previous study of CopZ are entirely 
consistent with an important role for BSH in copper speciation in the cytoplasm and its export out of 
the cell. 
 
Concluding remarks 
ESI-MS under non-denaturing conditions has provided high resolution information on CopAab 
assembly state and the precise nature of Cu(I)-bound species. Monomeric CuCopAab and Cu2CopAab 
are the main forms at levels of copper lower than 1/CopAab. Above this level, CopAab dimerization 
was observed, with the major dimeric species corresponding to Cu6(CopAab)2, with much smaller 
peaks due to Cu5(CopAab)2 and Cu4(CopAab)2 and no higher order copper bound forms, suggesting 
that Cu6(CopAab)2 is the most stable form of dimeric CopAab. The observation of two distinct 
dimeric charge state envelopes indicated the presence of distinct conformations that may be related 
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to previous observations of loss of secondary structure at higher copper loadings. The physiological 
importance of CopAab dimerization and Cu(I)-mediated unfolding is unclear, but one possibility is 
that this serves some kind of regulatory function perhaps through modulating interactions with 
transmembrane domains.  While any such regulatory role in CopA remains to be demonstrated, we 
note that formation of a Cu(I)-transporting P-type ATPase (ATP7B, the Wilson disease protein) dimer 
was recently reported in vitro and in cells [29].   
The influence of low molecular weight thiols on CopAab species distribution at elevated 
copper loadings (4 Cu/protein) was investigated and this confirmed that DTT efficiently inhibited 
CopAab dimer formation, and led to DTT adducts of CopAab, in which DTT most likely provides 
additional coordinating thiolate ligands that enable the formation of monomeric forms of CopAab 
capable of binding multiple Cu(I) ions, e.g., Cu6CopAab(DTT)2. In contrast, BSH was found to promote 
the formation of dimeric CopAab relative to monomeric forms, at least up to 10 BSH/CopAab. 
Species detected included Cu5(CopAab)2 and Cu6(CopAab)2, but also Cu7(CopAab)2, which was not 
detected in the absence of BSH, as well as the BSH adduct Cu6(CopAab)2(BSH). The data are 
consistent with BSH playing an important role in copper trafficking in B. subtilis. 
 
 
Table of abbreviations 
AUC analytical ultracentrifugation 
BSH bacillithiol 
CD circular dichroism 
CV column volume 
ESI-MS electrospray ionisation mass spectrometry 
DTT dithiothreitol 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
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NMR nuclear magnetic resonance 
MBD metal-binding domain 
SEC size exclusion chromatography 
SDS-PAGE sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
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Table 1.  Observed and predicted masses of CopAab with variable copper loadings detected by ESI-
MS. 
CopAab with variable Cu in absence of low molecular weight thiol 
Species 
Predicted 
mass (Da) 
Observed masses (Da) 
0.5 
Cu/CopAab 
1.0 
Cu/CopAab 
2.0 
Cu/CopAab 
4.0 
Cu/CopAab 
CopAab 15913 15911 15908 15908 15908 
CuCopAab 15976 15975 15974 15973 15973 
Cu2CopAab 16038 16038 16038 16037 16038 
Cu3(CopAab)2 32014 – – – – 
Cu4(CopAab)2 32076 – – 32073 32071 
Cu5(CopAab)2 32139 – 32139 32139 32140 
Cu6(CopAab)2 32201 – 32201 32201 32202 
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Figure 1. m/z mass spectra reveal two dimeric forms of CopAab. The mass spectra prior to, and 
after, deconvolution of CopAab reconstituted with Cu(I) at: A) 0.5 Cu / protein, B) 1 Cu / protein, C) 2 
Cu / protein, D) 4 Cu / protein. (•) = sodium adduct. CopAab (5 μM) was in 20 mM ammonium 
acetate. 
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Figure 2. Deconvoluted mass spectra for 4 Cu/CopAab at increasing levels of DTT. Mass spectra of 4 
Cu / CopAab in the presence of: A) 1 DTT / protein, B) 5 DTT / protein, C) 10 DTT / protein, D) 25 DTT 
/ protein. The regions of the mass spectra, from left to right, are: CopAab monomer, DTT adducts of 
CopAab monomer, and CopAab dimer. 
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Table 2.  Observed and predicted masses of ESI-MS detected CopAab in the presence of 4 Cu(I) per 
protein and variable low molecular weight thiols. 
Species 
Predicted 
mass (Da) 
Observed mass (Da) 
4 Cu/CopAab in presence of variable DTT 
  1 DTT / 
CopAab 
5 DTT / 
CopAab 
10 DTT / 
CopAab 
25 DTT / 
CopAab 
CopAab 15913 15909 – 15908 – 
CuCopAab 15976 15974 15976 15976 15976 
Cu2CopAab 16038 16037 16038 16038 16038 
Cu3CopAab 16101 16098 – – 16100 
Cu4CopAab 16163 16164 16163 16164 16164 
Cu4(CopAab:DTT) 16317 16318 16317 16318 16317 
Cu5(CopAab:DTT) 16380 – 16383 16382 16380 
Cu5(CopAab:DTT)2 16534 – 16532 – 16534 
Cu6(CopAab:DTT) 16442 – 16443 16444 – 
Cu6(CopAab:DTT)2 16597 16597 16597 16599 16596 
Cu4(CopAab)2 32076 32072 – – – 
Cu5(CopAab)2 32139 32136 – – – 
Cu6(CopAab)2 32201 32202 – – – 
 
4 Cu/CopAab in presence of variable BSH 
  1 BSH / 
CopAab 
5 BSH / 
CopAab 
10 BSH / 
CopAab 
25 BSH / 
CopAab 
CopAab 15913 15909 15909 15909 15910 
CuCopAab 15976 15975 15973 15973 15974 
Cu2CopAab 16038 – – – – 
Cu3CopAab 16101 – – – 16100 
Cu4CopAab 16163 16163 16163 16163 16165 
Cu4(CopAab)2 32076 – – – 32074 
Cu5(CopAab)2 32139 32137 32135 32138 – 
Cu6(CopAab)2 32201 32203 32203 32201 32202 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
23 
 
Cu7(CopAab)2 32264 32265 32264 32266 32264 
Cu8(CopAab)2 32326 32326 32325 32329 – 
Cu5(CopAab)2(BSH) 32692 – – – 32693 
Cu6(CopAab)2(BSH) 32756 32745 32746 32745 32753 
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Figure 3. Deconvoluted mass spectra for 4 Cu/CopAab at increasing BSH levels. The deconvoluted 
mass spectra of 4 Cu / CopAab in the presence of: A) 1 BSH / protein, B) 5 BSH / protein, C) 10 BSH / 
protein, D) 25 BSH / protein. 
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